NewslettersImmune Regulation NewsNOTCH1 Drives Sexually Dimorphic Immune Responses in Hepatocellular CarcinomaBy Jamie Kang - November 22, 2024023The authors demonstrated that NOTCH1, an understudied oncogene in hepatocellular carcinoma, elicits sexually dimorphic anti-tumor immunity and response to FDA-approved immunotherapies.[Cancer Discovery]Abstract